{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T14:01:49Z","timestamp":1702389709909},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T00:00:00Z","timestamp":1447200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142604","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T18:55:13Z","timestamp":1447268113000},"page":"e0142604","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Santiago","family":"Avila-R\u00edos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Garc\u00eda-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Tapia-Trejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita I.","family":"Meza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra M.","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leda","family":"Parham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma A.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Valladares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa M.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dixiana","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Moti\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Umanzor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candy","family":"Carbajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivette","family":"Lorenzana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa Y.","family":"Palou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Reyes-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,11]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. UNAIDS Gap Report 2014. Available: http:\/\/www.unaids.org\/en\/resources\/campaigns\/2014\/2014gapreport\/gapreport<\/ext-link>. Accessed September 2015."},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"SY Rhee","year":"2015","journal-title":"PLoS medicine"},{"key":"ref3","unstructured":"WHO. WHO HIV drug resistance report 2012. Available: http:\/\/www.who.int\/hiv\/pub\/drugresistance\/report2012\/en\/<\/ext-link>. Accessed September 2015."},{"issue":"1","key":"ref4","first-page":"17","article-title":"Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world","volume":"14","author":"D Frentz","year":"2012","journal-title":"AIDS reviews"},{"issue":"4","key":"ref5","first-page":"256","article-title":"HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?","volume":"14","author":"AC Pineda-Pena","year":"2012","journal-title":"AIDS reviews"},{"key":"ref6","unstructured":"WHO. WHO HIV drug resistance strategy for the surveillance and monitoring of HIV drug resistance 2012. Available: http:\/\/www.who.int\/hiv\/pub\/drugresistance\/drug_resistance_strategy\/en\/<\/ext-link>. Accessed September 2015."},{"key":"ref7","unstructured":"WHO. Surveillance of HIV drug resistance in adults initiating antiretroviral therapy (pre-treatment HIV drug resistance), concept note. Available: http:\/\/www.who.int\/hiv\/pub\/drugresistance\/pretreatment_drugresistance\/en\/<\/ext-link>. Accessed September 2015."},{"key":"ref8","unstructured":"WHO. Surveillance of HIV drug resistance in adults receiving ART (Acquired HIV drug resistance), concept note. Available: http:\/\/www.who.int\/hiv\/pub\/drugresistance\/acquired_drugresistance\/en\/<\/ext-link>. Accessed September 2015."},{"key":"ref9","unstructured":"UNAIDS. UNAIDS Honduras. Available: http:\/\/www.unaids.org\/en\/regionscountries\/countries\/honduras<\/ext-link>. Accessed September 2015."},{"key":"ref10","unstructured":"UNAIDS. 2014 Progress reports submitted by countries. Available: http:\/\/www.unaids.org\/en\/dataanalysis\/knowyourresponse\/countryprogressreports\/2014countries<\/ext-link>. Accessed September 2015."},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1468-1293.2009.00747.x","article-title":"Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment","volume":"11","author":"W Murillo","year":"2010","journal-title":"HIV medicine"},{"key":"ref12","unstructured":"UNDP. United Nations Development Programme Report. Country Evaluation: Honduras. Available: http:\/\/web.undp.org\/evaluation\/documents\/ADR\/ADR_Reports\/ADR_Honduras.pdf<\/ext-link>. Accessed September 2015."},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/aid.2007.0172","article-title":"Prevalence of resistance mutations in HIV-1-Infected Hondurans at the beginning of the National Antiretroviral Therapy Program","volume":"24","author":"B Lloyd","year":"2008","journal-title":"AIDS research and human retroviruses"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcv.2010.03.013","article-title":"Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras","volume":"49","author":"W Murillo","year":"2010","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/aid.2014.0057","article-title":"HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010\u20132013","volume":"31","author":"S Avila-Rios","year":"2015","journal-title":"AIDS research and human retroviruses"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PloS one"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"SY Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"ref18","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and uses of a public HIV drug-resistance database","volume":"194","author":"RW Shafer","year":"2006","journal-title":"The Journal of infectious diseases"},{"key":"ref19","article-title":"HIVdb Program"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"TF Liu","year":"2006","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref21","article-title":"REGA HIV Subtyping Tool v3.0"},{"key":"ref22","article-title":"RIP Tool"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0","volume":"30","author":"K Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"ref24","article-title":"Los Alamos HIV Database"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/infdis\/jis659","article-title":"HIV incidence determination in the United States: a multiassay approach","volume":"207","author":"O Laeyendecker","year":"2013","journal-title":"The Journal of infectious diseases"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.annepidem.2012.04.002","article-title":"The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response","volume":"22","author":"SA Strathdee","year":"2012","journal-title":"Annals of epidemiology"},{"key":"ref27","unstructured":"ONUSIDA. ONUSIDA Honduras. Available: http:\/\/www.onusida.hn\/<\/ext-link>. Accessed September 2015."},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/infdis\/jiq167","article-title":"Differential persistence of transmitted HIV-1 drug resistance mutation classes","volume":"203","author":"V Jain","year":"2011","journal-title":"The Journal of infectious diseases"},{"issue":"15","key":"ref29","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/QAD.0000000000000768","article-title":"A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK","volume":"29","author":"R Mourad","year":"2015","journal-title":"Aids"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/jiv012","article-title":"Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012","volume":"212","author":"WL Yang","year":"2015","journal-title":"The Journal of infectious diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:56:33Z","timestamp":1540032993000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142604"}},"subtitle":[],"editor":[{"given":"Paul Richard","family":"Harrigan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,11]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142604","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,11]]}}}